©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Molecular Cloning and Functional Expression of Murine JE (Monocyte Chemoattractant Protein 1) and Murine Macrophage Inflammatory Protein 1 Receptors
EVIDENCE FOR TWO CLOSELY LINKED C-C CHEMOKINE RECEPTORS ON CHROMOSOME 9 (*)

(Received for publication, August 24, 1995; and in revised form, December 20, 1995)

Landin Boring (1) (3) Jennifa Gosling (1) Felipe S. Monteclaro (1) Aldons J. Lusis (4) Chia-Lin Tsou (1) Israel F. Charo (1) (3) (2)(§)

From the  (1)Gladstone Institute of Cardiovascular Disease, San Francisco, California 94141-9100, the (2)Department of Medicine and the (3)Daiichi Research Center, University of California, San Francisco, California 94143, and the (4)Department of Microbiology and Molecular Genetics and the Department of Medicine, University of California, Los Angeles, California 90024-1679

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

We have isolated cDNA clones that encode two closely related, murine C-C chemokine receptors. Both receptors are members of the G-protein-coupled, seven-transmembrane domain family of receptors and are most closely related to the human monocyte chemoattractant protein 1 receptor. Expression of each of the receptors was detected in murine monocyte/macrophage cell lines, but not in nonhematopoietic lines. Expression of these receptors in Xenopus oocytes revealed that one receptor signaled in response to low nanomolar concentrations of murine JE, whereas the second receptor was activated by murine macrophage inflammatory protein (MIP) 1alpha and the human chemokines MIP-1beta and RANTES. Binding studies revealed high affinity binding of radiolabeled mJE to the mJE receptor and murine MIP-1alpha to the second receptor. Chromosomal localization indicated that the two receptor genes were clustered within 80 kilobases of each other on mouse chromosome 9. Creation of receptor chimeras suggested that the amino terminus was critically involved in mediating signal transduction and ligand specificity of the mJE receptor, but not the mMIP-1alpha receptor. The identification and cloning of two functional murine chemokine receptors provides important new tools for investigating the roles of these potent cytokines in vivo.


INTRODUCTION

Leukocyte trafficking plays an important role in immune system surveillance and chronic inflammation. Locally produced chemoattractant cytokines, known as chemokines, are thought to play a critical role in this directed migration (see (1, 2, 3, 4) for recent reviews). Human monocyte chemoattractant protein 1 (hMCP-1) (^1)and its murine homolog, JE (mJE), are members of the C-C family of chemokines, in which the first two of four conserved cysteines are adjacent to each other. Other C-C chemokines include macrophage inflammatory protein 1alpha and 1beta (MIP-1alpha, MIP-1beta) and RANTES (regulated on activation, normal T cell-expressed). In general, C-C chemokines are potent monocyte and lymphocyte chemoattractants. A C-C chemokine that is a chemoattractant for eosinophils, eotaxin(5) , has recently been described, as well as a novel lymphocyte chemokine containing two, rather than four cysteines, known as lymphotaxin(6) .

The murine JE gene was originally identified by virtue of its dramatic induction in murine fibroblasts by platelet-derived growth factor and other growth factors(7) . Characterization of the gene by Rollins et al.(8) revealed important similarities to known cytokines such as macrophage colony-stimulating factor, interferon alpha, and interleukin (IL) 6. Murine JE and hMCP-1 are 62% identical over their amino-terminal domains, but mJE extends an additional 49 amino acids beyond the carboxyl end of hMCP-1. This carboxyl-terminal extension, which is extensively glycosylated, is not required for the chemoattractant activity of mJE(9) . Further, mJE and hMCP-1 have similar chemoattractant activity for human monocytes(9) . Murine JE is thus a structural and functional analog of hMCP-1.

MCP-1 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, including psoriasis(10) , pulmonary fibrosis (11) , rheumatoid arthritis(12) , and atherosclerosis(13, 14) . In mice, mJE has been shown to be up-regulated by infusion of minimally oxidized low density lipoproteins (15) and thus may play a role in the accumulation of monocyte/macrophages in early atherosclerotic lesions. A possible role for mJE in tumor suppression in vivo was suggested by Rollins et al.(16) who found that expression of hMCP-1 or mJE in Chinese hamster ovary cells suppressed the ability of the cells to form tumors in nude mice.

Human receptors for IL-8 (Type A and Type B(17, 18) ) and a single receptor that binds both RANTES and MIP-1alpha (19, 20) have been cloned and shown to be members of the seven-transmembrane domain superfamily of receptors. We have recently reported the cloning and expression of two alternatively spliced forms of the human MCP-1 receptor, which differ only in their terminal carboxyl tails (21) and which couple to G in a pertussis toxin-sensitive manner(22) . To investigate further the roles of chemokines in vivo, considerable effort has been focused recently on the cloning of their murine receptors. In contrast to the situation in the human, a single receptor appears to exist for murine IL-8(23) . Extramedullary myelopoiesis, as well as a decreased neutrophil response after injection of thioglycolate, was noted in mice in which the IL-8 receptor was deleted by homologous recombination(23) . These studies suggest that IL-8, and perhaps other chemokines, are involved in the regulation of myelopoiesis. Gao and Murphy (24) have very recently reported the cloning of a murine MIP-1alpha receptor, as well as two orphan receptors. In this paper, we report the cloning and functional expression of a murine JE/MCP-1 receptor, as well as a second, closely related receptor that signals in response to mMIP-1alpha, hMIP-1beta, and hRANTES.


MATERIALS AND METHODS

Reagents

Recombinant chemokines were obtained from R & D Systems, Inc. (Minneapolis, MN). Initial experiments used full-length mouse (9) and rat JE purified from supernatants of stably transfected Chinese hamster ovary cells (kindly provided by T. Yoshimura, National Cancer Institute, Frederick, MD, and B. Rollins, Dana Farber Cancer Institute, Boston, MA). Murine JE expressed in Escherichia coli (R & D Systems, Inc.) was used in subsequent experiments. No differences in activity were observed between the JE expressed in E. coli versus mammalian cells. LipofectAMINE and G418 sulfate were from Life Technologies, Inc. Restriction enzymes were from Boehringer Mannheim. Ca was obtained from Amersham. All other reagents were obtained from Sigma.

Tissue Culture, Calcium Fluorimetry, and Stable Transfections

WEHI 3, WEHI 274.1, and WEHI 265.1 cells were obtained from the American Type Culture Collection (Bethesda, MD) and were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Hyclone Laboratories, Logan, UT) and 1% penicillin/streptomycin, at 37 °C in a humidified 5% CO(2) atmosphere. P388D1 cells, obtained from the American Type Culture Collection, were grown in RPMI 1640 containing 10% fetal calf serum and antibiotics. All other cell lines were grown in Dulbecco's modified Eagle's medium with 10% fetal calf serum plus antibiotics. For calcium fluorimetry, cells were grown to log phase, loaded with the calcium-specific dye Indo-1 AM (Molecular Probes, Eugene, OR), and assayed by spectrofluorimetry for changes in the concentration of intracellular calcium ([Ca](i)) in response to chemokines as described(22) . To generate stable cell lines that expressed murine chemokine receptors, human embryonic kidney (HEK)-293 cells, obtained at passage 36 from the American Type Culture Collection, were grown in modified Eagle's medium/Earle's balanced salt solution with 10% fetal calf serum and antibiotics. Murine receptors were cloned into the polylinker of the mammalian expression vector pcDNA3 (Invitrogen, San Diego, CA) and transfected into HEK-293 cells (50-80% confluent) with a DNA/lipofectAMINE mixture according to the manufacturer's instructions. Cells were grown in the presence of G418 (0.8 mg/ml) for 3-6 weeks. Surviving colonies were assayed by Northern blot, and clones expressing high levels of receptor RNA were expanded for further studies.

cDNA Library Construction and Screening

WEHI 274.1 cells were grown to log phase, and responsiveness to JE was confirmed by demonstrating an intracellular calcium flux in Indo-1-loaded cells. Total RNA was harvested from 5 times 10^8 cells using the Trizol reagent (Life Technologies, Inc.) following the manufacturer's instructions, and poly(A) RNA was selected using oligo(dT)-cellulose (Pharmacia Biotech Inc.). A cDNA library was constructed from 5.0 µg of poly(A) RNA using the Lambda ZapII cDNA Kit (Stratagene) according to the manufacturer's instructions. Analysis of the library revealed an average insert size of 2.0 kb. Approximately 1.5 times 10^6 plaque-forming units were screened with a P-labeled probe from the 5` end of the human MCP-1 receptor (base pairs 227-512 of the MCP-1R cDNA), in a hybridization solution of 30% deionized formamide, 2 times PIPES, 5 times Denhardt's, 5% dextran sulfate, 0.5% SDS, and 100 µg/ml salmon sperm DNA at 42 °C. Filters were washed in 0.1 times SSC/0.1% SDS at 55 °C until background counts stopped decreasing on control filters. Positive clones were subjected to three rounds of plaque purification, and phagemids (pBluescript SK) containing inserts were excised according to the manufacturer's instructions. Ten positive clones were characterized, which contained inserts ranging in size from 2.0 to 4.0 kb. We also screened a mouse spleen cDNA library cloned in Lambda Zap (Stratagene) with a probe derived from the full-length MCP-1 receptor cDNA, using the same hybridization conditions as above. Fifteen positive clones were obtained from 1.0 times 10^6 plaque-forming units. Inserts were sequenced using fluorescently labeled dideoxynucleotides(25) .

Calcium Efflux Assay

The calcium efflux assay was performed as described(21) . Briefly, cDNAs were cloned downstream of the SP6 promoter of pcDNA3, the plasmid was linearized, and complementary RNA (cRNA) was transcribed using SP6 RNA polymerase. The size and concentration of the transcription product were confirmed by gel electrophoresis. Xenopus laevis oocytes were injected with 25 ng of cRNA in a total volume of 50 nl per oocyte 1 day after harvesting. After incubation in modified Barth's medium (21) for 2 days at 16 °C, the oocytes were loaded with Ca (50 mCi/ml, Amersham) for 3 h, washed for 1 h, and placed in groups of seven into wells of a 24-well plate in a volume of 0.5 ml. Expression of recombinant receptors at the oocyte surface was confirmed using an enzyme-linked immunosorbent assay, as described(26) . The Ca efflux following addition of agonist was determined by collecting samples of the medium at 10-min intervals and counting beta emissions in a liquid scintillation counter. Agonists were applied to the oocytes in Barth's medium for 10 min. Uninjected oocytes were used as controls.

Chemokine Binding Assay

Binding studies were performed using membranes prepared from stable cell lines. Approximately 5 times 10^8 stably transfected HEK-293 cells were harvested by incubation with 1 mM EDTA in phosphate-buffered saline, washed once with phosphate-buffered saline, and resuspended in 25 ml of a hypotonic solution (10 mM Hepes, pH 7.2, 0.2 mM CaCl(2), 1 mM MgCl(2), 0.1% bovine serum albumin, 2 mM EDTA, 1 µM leupeptin, 1 mM phenylmethylsulfonyl fluoride, 0.7 µg/ml pepstatin, and 1 µg/ml DNase). The resuspended cells were homogenized using a Dounce homogenizer and sonicated for 45 s (Branson Model 450 sonicator, output level 5, Danbury, CT), centrifuged at 1000 times g for 10 min, and the supernatants collected. Membranes were obtained by centrifugation of the supernatants at 48,000 times g for 30 min at 4 °C. The membrane pellet was resuspended in binding buffer (50 mM Hepes, pH 7.4, 1 mM CaCl(2), 5 mM MgCl(2), 0.5% bovine serum albumin). Approximately 2.5 µg of cell membranes in 0.3 ml of binding buffer were added to 12 times 75 mm polypropylene tubes containing murine JE that had been radiolabeled with I by the Bolton-Hunter procedure (DuPont NEN) to a specific activity of 2200 Ci/mmol. After incubation for 90 min at 27 °C with gentle shaking, the membranes were collected onto a glass fiber filter (presoaked in 0.3% polyethyleneimine, 0.2% bovine serum albumin for 1 h), using a SKATRON filtration harvester (Sterling, VA), set at a vacuum pressure of 500 mm Hg. Unbound ligand was removed by the addition of 4 ml of wash buffer (10 mM Hepes, 0.5 M NaCl, 0.5% bovine serum albumin) over an interval of 10 s. Bound I-JE was quantitated by counting emissions. Essentially identical results were obtained using intact transfected HEK-293 cells, but with a higher level of nonspecific binding. In the case of the mMIP-1alpha receptor, binding was performed using I-Bolton-Hunter-labeled mMIPalpha and stably transfected HEK-293 cells. Dissociation constants were calculated by the method of Scatchard using the program LIGAND(27) . Binding data were plotted, and IC values were determined using the program Prism (by Graph Pad, San Diego, CA).

Southern and Northern Blot Analysis

For Southern blots, 10 µg of mouse genomic DNA was digested with restriction enzymes, fractionated by size on a 0.6% agarose gel, and transferred to Zetaprobe-GT (Bio-Rad) nylon membranes according to the manufacturer's instructions. The membrane was sequentially hybridized with probes specific for the murine MIP-1alpha and JE receptors. These probes were derived from the 3`-untranslated regions of the corresponding cDNAs, and their specificities were confirmed by hybridization to increasing concentrations of both cDNAs spotted onto nitrocellulose membranes. Prior to reprobing, the membrane was stripped by incubation in 0.4 N NaOH at 45 °C for 30 min, followed by washing in 0.1 times SSC/0.1% SDS at 65 °C for 2 h. The membrane was also hybridized with a probe that detects both receptors (corresponding to nucleotides 335-620 of the mJE receptor cDNA, which encode the highly conserved region from transmembrane domain (TM) 1 through TM3). Probes were labeled with [P]dCTP to a specific activity of >8.0 times 10^9 cpm/µg and used at a concentration of 4.0 times 10^6 cpm/ml. Hybridizations were performed in 50% deionized formamide, 5 times SSC, 5 times Denhardt's, 1.0% SDS, and 100 µg/ml denatured salmon sperm DNA at 42 °C for 16 h. The membrane was washed in 0.1 times SSC/0.1% SDS at 55 °C for 3 h and exposed to x-ray film with intensifying screens for 1-3 days at -80 °C.

For Northern blots, 10 µg of total RNA was size-fractionated on a 1.0% agarose, 0.66 M formaldehyde gel, transferred to a nylon membrane (Hybond-N, Amersham), and stained with 0.03% methylene blue in 0.3 M sodium acetate, pH 5.2, to visualize ribosomal RNAs. The filter was sequentially hybridized with P-labeled receptor-specific probes described above. The probe concentration was 1.0 times 10^6 cpm/ml, and hybridizations were at 42 °C overnight in the above hybridization mixture, except that 5% dextran sulfate was included and PIPES (0.8 M NaCl, 20 mM PIPES, pH 6.5) replaced the SSC. The membrane was stripped by boiling for 10 min in water containing 0.5% SDS.

P1 Clones

Murine genomic bacteriophage P1 clones containing each of the two receptors were obtained using PCR primer pairs. A 129 ES mouse genomic library (average insert size of 85 kb) was screened by Genome Systems (St. Louis, MO) using primer pairs specific for each receptor. The mMIP-1alpha receptor (MIP-1alpha-R) primers were located at nucleotides 1015-1033 (sense) and 1144-1164 (antisense) of the cDNA and the JE receptor primers at nucleotides 1360-1378 (sense) and 1593-1612 (antisense) of the cDNA. Of five positive clones for the mMIP-1alpha receptor, four also produced a specific product using the JE receptor primer pair. We further characterized two of the double positive clones by PCR and confirmed that both primer pairs amplified a specific product from each P1 clone. The PCR reactions included 0.19 µg of P1 DNA template, 100 pM concentration of each primer, and 2.5 units of Pfu DNA polymerase (Stratagene) in a volume of 100 µl. The PCR conditions were 95 °C for 5 min, followed by 30 cycles of 95 °C for 30 s, 50 °C for 60 s, and 72 °C for 2 min. PCR products were separated on a 1.8% agarose gel and stained with ethidium bromide.

Chromosomal Localization

The genes for mJE-R and mMIP-1alpha-R were mapped by linkage analysis of an interspecific backcross of (C57BL/6J times Mus spretus) F1 times C57BL/6J mice, constructed as described previously(28) . The cross was previously typed for several hundred restriction fragment length variants (RFLVs) and simple sequence repeat length polymorphisms(28) . To identify informative RFLVs, DNAs from the parental strains were digested with various restriction enzymes and subjected to Southern hybridization analysis as described above. A survey of restriction enzymes revealed an RFLV for the mJE receptor gene with the enzyme PvuII. Following digestion with PvuII, DNA from parental strain C57BL/6J exhibited a 6.2-kb hybridizing fragment, DNA from M. spretus exhibited 3.8-kb and 1.6-kb fragments, and DNA from F1 hybrids exhibited all three fragments (not shown). A survey of restriction enzymes revealed an RFLV for the mMIP-1alpha receptor gene using the enzyme HindIII; thus, following digestion, DNA from strain C57BL/6J exhibited bands of 16 kb and 7.2 kb, DNA from M. spretus exhibited a band of 6.4 kb, and DNA from F1 mice exhibited all three bands. The RFLVs were then examined in a set of backcross mice, and the segregation patterns were compared with those of previously typed markers.

Chimeric Receptors

The amino termini of the two murine receptors were interchanged by taking advantage of a conserved EcoRV site located within the putative first intracellular loop of each receptor (residue 92 of the mJE-R and residue 69 of the mMIP-1alpha-R). These chimeric receptors, designated mJE/mMIP-1alpha-R and mMIP-1alpha/mJE-R, were expressed and assayed for signaling in Xenopus oocytes as described above.


RESULTS

Cloning and Expression of Murine Chemokine Receptors

To identify cell lines expressing the mJE receptor, we screened murine monocyte/macrophage cell lines for responsiveness to mJE and related C-C chemokines. As shown in Fig. 1, mJE and, to a lesser extent, hMCP-1 induced a transient intracellular calcium flux in WEHI 274.1 cells. Calcium fluxes were not observed in WEHI 265.1, WEHI 3, or P388D1 cells (data not shown). To clone the mJE receptor, we constructed a cDNA library from the WEHI 274.1 cells and screened this library with a probe complementary to a highly conserved region of the human MCP-1R. A 2.9-kb cDNA clone was obtained that conferred mJE- and hMCP-1-dependent signaling, when expressed in Xenopus oocytes, as assayed by Ca efflux (Fig. 2). This receptor was specific for JE/MCP-1, as no calcium efflux was observed in response to the closely related C-C chemokines mMIP-1alpha, mMIP-1beta, hRANTES, hMIP-1alpha, or hMIP-1beta (Fig. 2A). In addition, HEK-293 cells stably expressing this cDNA also underwent a robust intracellular calcium flux in response to mJE (1-30 nM) (Fig. 3A), thus confirming that this receptor signals in mammalian cells. Human MCP-1 also elicited a calcium flux, although at higher concentrations than mJE (Fig. 3B). A small but reproducible signal was seen in response to mMIP-1alpha (100 nM), but not to hMIP-1alpha, hMIP-1beta, or hRANTES (Fig. 3C). We therefore refer to this cDNA clone as the mJE receptor.


Figure 1: Calcium mobilization in WEHI 274.1 cells by mJE and hMCP-1. WEHI 274.1 cells were loaded with Indo-1 AM and challenged with mJE (30 nM) or hMCP-1 (100 nM) at the time indicated by the arrow.




Figure 2: Expression of the mJE receptor in Xenopus oocytes. A, specificity of the mJE receptor. All chemokines were used at a final concentration of 100 nM. B, dose-response curves for mJE and hMCP-1. All data points were determined in triplicate. The data shown are representative of three experiments.




Figure 3: Calcium mobilization in 293 cells stably transfected with the mJE receptor cDNA. Dose-response curves to mJE (A), hMCP-1 (B), and other C-C chemokines (100 nM) (C).



Screening of a mouse spleen library yielded a second cDNA clone that also hybridized strongly to the hMCP-1 receptor probe. In contrast to the mJE receptor, however, the receptor encoded by this cDNA signaled in response to mMIP-1alpha, hRANTES, and hMIP-1beta, but did not respond to mJE, hMCP-1, mMIP-1beta, or hMIP-1alpha (Fig. 4). We therefore refer to this receptor as the murine MIP-1alpha (mMIP-1alpha) receptor. The response of this receptor to murine, but not human MIP-1alpha, is intriguing, as the human MIP-1alpha/RANTES (C-C CKR-1) receptor responds equally well to both human and murine MIP-1alpha(19) .


Figure 4: Expression of the murine MIP-1alpha receptor in Xenopus oocytes. A, specificity of the mMIP-1alpha receptor. The indicated chemokines were used at final concentrations of 100 nM. B, dose-response curves for mMIP-1alpha and hMIP-1beta. All data points were determined in triplicate. The data shown are representative of three similar experiments.



Binding of Radiolabeled Chemokines

Radiolabeled JE bound with high affinity to membranes prepared from HEK-293 cells expressing the putative JE receptor (Fig. 5A). Analysis of these binding data by the method of Scatchard revealed a dissociation constant (K(d)) of 46 pM. In competition binding assays using 150 pMI-labeled JE, we observed very similar IC values for unlabeled JE (195 pM) and human MCP-1 (210 pM) (Fig. 5B). HEK-293 cells expressing the mMIP-1alpha receptor bound I-mMIP1alpha with high affinity (K(d) = 640 pM) (Fig. 5C). In competition assays, we found that unlabeled hMIP-1beta, as well as mMIP-1alpha, competed efficiently with I-mMIP-1alpha for binding to the receptor (data not shown).


Figure 5: Binding of chemokines to the cloned receptors. A, radiolabeled mJE was added at the indicated concentrations to membranes prepared from HEK-293 cells stably expressing the mJE receptor. Nonspecific binding was determined by the addition of a 100-fold excess of unlabeled JE. Specific binding was determined by subtraction of the nonspecific binding from the total binding. The dissociation constant (K), determined by Scatchard analysis, was 46 ± 18 pM. Shown is one of three similar experiments. Very similar results were obtained using intact HEK-293 cells. B, competition of mJE and hMCP-1 for the mJE receptor. Radiolabeled mJE (150 pM) was added to membranes prepared from HEK-293 cells stably expressing the mJE receptor. Unlabeled mJE and hMCP-1 were added at the indicated concentrations. The IC values were 195 pM for mJE and 210 for hMCP-1. C, radiolabeled mMIP-1alpha was added at the indicated concentrations to HEK-293 cells stably expressing the mMIP-1alpha receptor. Nonspecific binding was determined by the addition of a 100-fold excess of unlabeled mMIP-1alpha. The apparent K was 640 pM.



Sequence Similarity of the Murine and Human C-C Chemokine Receptors

The murine JE receptor cDNA encoded a protein of 373 amino acids (Fig. 6). Hydropathy analysis of the predicted amino acid sequence revealed seven putative transmembrane domains and an extracellular amino terminus of 50 residues. The mJE receptor was closely related to the MCP-1 receptor, being 75% identical overall at the amino acid level. The carboxyl-terminal tail of the mJE receptor was 81% identical with the corresponding region of the ``B'' form of the human hMCP-1 receptor (21) and did not resemble the type ``A'' receptor tail(21) . The second novel murine cDNA, the mMIP-1alpha receptor, encoded a seven-transmembrane domain receptor of 354 amino acids, that was more closely related to the hMCP-1R (71% identity) than to the hMIP-1alpha/RANTES-R (Table 1)(19, 20) . The two murine receptors were 72% identical overall. However, the transmembrane (TM) domains and intracellular loops, particularly in the region of the second and third TMs, were almost identical. Conversely, the amino termini, the second and third extracellular loops, and the carboxyl-terminal tails were less well conserved between the two murine receptors (Fig. 6), suggesting that these regions may be involved in determining chemokine specificity.


Figure 6: Predicted amino acid sequence of the mJE and mMIP-1alpha receptors. The murine receptors are shown aligned with the human C-C chemokine receptors. Gaps inserted to optimize the alignments are indicated by dashes. The seven predicted transmembrane domains are indicated by the horizontal bars and numbers.





Chromosomal Localization of mJE and mMIP-1alpha Receptors

Hybridization of murine genomic DNA with probes specific for the mJE and mMIP-1alpha receptors revealed single bands in each lane of the Southern blot, suggesting that each receptor is encoded by a single copy gene (Fig. 7). Rehybridization of this same blot with a probe derived from a highly conserved portion of the coding region of these two receptors (TM1 to TM3) failed to reveal additional bands, suggesting the absence of other closely related receptors (data not shown).


Figure 7: Southern blot analysis of murine chemokine receptor genes. Mouse genomic DNA (10 µg) was digested with HindIII (lane 1), EcoRI (lane 2), BamHI (lane 3), or XbaI (lane 4) and hybridized under conditions of high stringency with radiolabeled probes specific for the 3`-untranslated regions of the mJE and mMIP-1alpha receptors.



The chromosomal locations of the two genes were determined by linkage analysis of an interspecific backcross involving the parental mouse strains C57BL/6J and M. spretus as described previously (28) . Receptor-specific probes were used to identify informative RFLVs of the genes upon Southern hybridization. The segregation of the RFLV was examined in 65 (C57BL/6J times M. spretus) F1 times C57BL/6J backcrossed mice. DNA from these mice has been typed previously for over 200 genetic markers spanning all chromosomes except the Y chromosome(28) . The mJE receptor RFLV exhibited linkage with a number of markers on the distal portion of mouse chromosome 9, the nearest proximal marker being the microsatellite marker D9Mit19 (1 recombinant out of 65 animals) and the nearest distal marker being the random cDNA RFLV D9Ucla3 (1 recombinant out of 65 animals) (Fig. 8). The linkage was highly significant, as both markers exhibited logarithm of the odds scores exceeding 17.3. Analysis of the segregation of an RFLV for the mMIP-1alpha receptor gene revealed complete co-segregation with the mJE receptor RFLV (no recombination out of 65 animals). These results indicate that the genes for the mJE receptor and the mMIP-1alpha receptor are tightly linked on mouse chromosome 9 (Fig. 8). The results indicate the following order of markers typed on distal chromosome 9, with distances given in centimorgans ± S.E.: centromere-(D9Ucla2, D9Mit36) ( 5.9 ± 3.3 centimorgans)-2Mit6 h2 (1.5 ± 1.5 centimorgans)- D9Mit19 (1.5 ± 1.5 centimorgans)-(Jer, Mip1ar) (1.5 ± 1.5 centimorgans)-D9Ucla3 (1.5 ± 1.5 centimorgans)-D9Ucla5. We designate the symbols Jer and Mip1ar for the JE receptor and MIP-1alpha receptor, respectively. This region of murine chromosome 9 is syntenic to human chromosome 3p21(29) .


Figure 8: Chromosomal localization of the JE and MIP-1alpha receptors. Restriction fragment length variants (RVLPs) between C57BL/6J and M. spretus mice were used to map the murine receptors as described under ``Materials and Methods.'' Both receptors map to adjacent locations near the distal part of murine chromosome 9. The distances, in centimorgans, between the chromosome 9 markers mapped in this cross are indicated(28) .



Further evidence that the two receptors are closely linked was obtained by screening a murine 129ES genomic library constructed in P1 bacteriophage clones (average insert size of 85 kb). Using PCR primer pairs specific for each receptor (see ``Materials and Methods''), we obtained two independent P1 clones that amplified the predicted products for both receptors (Fig. 9). In addition, Southern analysis of one P1 clone (clone 5340) produced the same hybridization pattern with receptor-specific probes as that observed with total genomic DNA (data not shown, see Fig. 7), indicating that this P1 clone contains both the mJE and mMIP-1alpha receptors. We conclude, therefore, that these two receptors are closely linked on mouse chromosome 9.


Figure 9: PCR analysis of P1 bacteriophage genomic clones. mJE and mMIP-1alpha receptor-specific primers were used to amplify the indicated DNA templates. Lane 1, mMIP-1alpha receptor cDNA; lane 2, mJE receptor cDNA; lane 3, P1 clone 5203 and mMIP-1alpha receptor primers; lane 4, P1 clone 5203 and mJE receptor primers; lane 5, P1 clone 5340 and mMIP-1alpha receptor primers; lane 6, P1 clone 5340 and mJE receptor primers. No bands were seen when mJE receptor primers were used with the mMIP-1alpha receptor cDNA as the template and vice versa (not shown).



Expression of the JE Receptor and the MIP-1alpha Receptor in Murine Monocytic Cell Lines

We examined a number of hematopoietic and nonhematopoietic murine cell lines for expression of the mJE receptor and the mMIP-1alpha receptor. As shown in Fig. 10, the mJE receptor mRNA was expressed by monocytic WEHI 274.1 cells and at lower levels by WEHI 265.1 and WEHI 3 cells. P388D1 cells, a macrophage-like line, and a variety of non-myeloid cell lines did not express detectable levels of the mJE receptor mRNA. Conversely, the mMIP-1alpha receptor message was expressed at high levels by P388D1 cells, at much lower levels by WEHI 265.1 cells, but was not detectable in the other cell lines tested (Fig. 10). These results are consistent with the observations that WEHI 274.1 cells respond to mJE (Fig. 1), and that P388D1 cells respond to hRANTES and mMIP-1alpha (Table 2).


Figure 10: Northern blot analysis of chemokine receptor expression by murine cell lines. Total RNA (10 µg/lane) from the indicated cell lines was electrophoresed in a 1% agarose gel and hybridized with radiolabeled probes specific for the mJE receptor and the mMIP-1alpha receptor. WEHI 274.1 and 265.1 are monocytic cell lines. WEHI 3 and P388D1 are macrophage cell lines. NS1 is a myeloma cell line. B16.F10 is a melanoma cell line. BALB/c, L929, and NIH3T3 are fibroblasts. Y1 is an adrenal tumor cell line. Exposure times were 2 days at -80 °C. The positions of 18 S and 28 S ribosomal RNAs are indicated to the left. Methylene blue staining of the filter revealed intact ribosomal bands of approximately equal intensity in all lanes, except for the BALB/c lane, in which the amount of RNA was reduced (data not shown).





Receptor Chimeras

To investigate the role of the amino terminus in ligand recognition and signaling, we constructed chimeric receptors in which the amino termini, along with TM1, were interchanged between the mJE receptor and the mMIP-1alpha receptor. These chimeric receptors were expressed in Xenopus oocytes and assayed for signaling in response to various chemokines. As shown in Fig. 11, the chimeric mJE/mMIP-1alpha receptor (amino terminus and TM1 from the mJE receptor spliced onto the mMIP-1alpha receptor) signaled well in response to mMIP-1alpha, and hRANTES, but did not signal in response to mJE or hMCP-1. This chimeric receptor, therefore, retained the same ligand specificity as the wild-type mMIP-1alpha receptor. In contrast, the complementary mMIP-1alpha/mJE receptor chimera failed to signal to any of the C-C chemokines (Fig. 11). Enzyme-linked immunosorbent assays confirmed that this chimera was expressed on the surface of microinjected oocytes at levels comparable to, or higher than, the wild-type receptors (data not shown). These data indicate, therefore, that the amino-terminal domain of the mJE receptor, but not the mMIP-1alpha receptor, is critically involved in receptor activation and signal transduction.


Figure 11: Expression of chimeric C-C chemokine receptors in Xenopus oocytes. The indicated chemokines were used at final concentrations of 200 nM.




DISCUSSION

Murine JE has been implicated in models of disease characterized by prominent monocyte/macrophage infiltrates, but the mechanisms of monocyte activation and directed migration induced by mJE are not well understood. To gain insight into this phenomenon, and as a first step in genetic modification of the mJE receptor gene, we have cloned its cDNA from a murine monocytic cell line. Several lines of evidence support the conclusion that this cDNA encodes a murine JE receptor. First, injection into Xenopus oocytes of cRNA obtained from this clone conferred mJE/hMCP-1-dependent activation at low nanomolar concentrations. We have confirmed these results in transfected mammalian cells. In both Xenopus oocytes and HEK-293 cells expressing the JE receptor, calcium is mobilized much more efficiently by mJE as compared to hMCP-1. Similar results were obtained using wild-type WEHI 274.1 murine monocytes. Second, these responses are specific for mJE/hMCP-1, as other closely related chemokines failed to induce signals. Third, I-labeled JE bound with high affinity to HEK-293 cells transfected with this cDNA. Fourth, Northern blot analysis revealed high levels of expression of the receptor mRNA in monocytic cell lines that responded to mJE and little or no mRNA in lines that failed to respond to mJE. Finally, sequencing of the cDNA revealed a putative seven-transmembrane domain receptor with a predicted amino acid sequence that was 72% identical with the hMCP-1 receptor. We conclude, therefore, that this cDNA encodes a murine JE receptor.

The second receptor cloned in this study signaled well in response to low nanomolar concentrations of murine MIP-1alpha and also bound this chemokine with high affinity. It is likely, therefore, that mMIP-1alpha is the natural ligand for this receptor. The mMIP-1alpha receptor also signaled in response to human MIP-1beta and thus represents the first example of a cloned receptor activated by MIP-1beta. In addition, hMIP-1beta competed well with radiolabeled mMIP-1alpha in receptor binding assays. Whether or not MIP-1beta is a natural ligand for this receptor remains unclear, however, because the murine form of MIP-1beta was not efficient at receptor activation. Similarly, this receptor was activated by human RANTES, and it will be interesting to determine if murine RANTES is a functional ligand.

The mJE and mMIP-1alpha receptors are almost completely identical in the putative transmembrane domains, as well as in the first extracellular loop. In addition, the second and third intracellular loops are nearly identical, suggesting that both receptors may couple to the same or very similar G-proteins. Interestingly, the murine MIP-1alpha receptor is more closely related to the MCP-1 receptor than to C-C CKR-1, the human receptor that binds and signals in response to MIP-1alpha and RANTES (19) . These data suggest that the MIP-1alpha receptor is a novel receptor and not simply a murine homolog of the human MIP-1alpha/RANTES receptor. Based on primary sequence identity, it may in fact represent the murine form of a human MCP-1 receptor homolog. This receptor does not, however, signal in response to human or murine MCP-1. The mJE receptor signals primarily in response to mJE and hMCP-1 and, in this regard, is very reminiscent of the ligand specificity of the hMCP-1 receptor. We have recently found that hMCP-3, but not hMCP-2, is a functional ligand for the human MCP-1 receptor(30) . It remains to be determined if the MARC/fic protein(31) , which appears to be the murine homolog of hMCP-3, activates the mJE receptor.

The cloned mJE receptor bound mJE and hMCP-1 in a comparable manner, yet signaled much more efficiently in response to mJE as compared to hMCP-1. High affinity binding of the ligand to the receptor thus appears to be necessary, but not sufficient, to initiate signaling. These data are consistent with a model in which one portion of the receptor binds the ligand with high affinity, while a second receptor domain interacts with the chemokine to initiate signaling. Recent work in our laboratory on the binding of hMCP-1 to its receptor supports such a model, (^2)as does published work on the C5a receptor(32) . It should be noted that hMCP-1 and mJE have been found to be equipotent in inducing chemotaxis of human monocytes(9) . Thus, unlike the murine receptor, the human MCP-1 receptor may not distinguish between human and murine MCP-1. Studies are currently in progress in our laboratory comparing the binding and signaling properties of the human and murine MCP-1 receptors.

The mJE and mMIP-1alpha receptors appear to have arisen by gene duplication and may represent the first two members of a family of receptor genes clustered on chromosome 9. The evidence for this hypothesis includes the high degree of identity between these two receptors at the DNA sequence level, their co-segregation in a genetic cross, and their co-localization on a P1 bacteriophage clone. This area of mouse chromosome 9 is syntenic to human chromosome 3p21, where the hMIP-1alpha/RANTES (20) and hMCP-1 (^3)receptor genes are found in close proximity. This region does not correspond to any mutations with obvious relevance to these receptors. In addition, Gao and Murphy (24) have very recently identified a murine MIP-1alpha receptor distinct from the receptors described in this paper, as well as two additional closely related murine receptors without identified ligands, all of which map to mouse chromosome 9. Other chemokine receptors have been localized to human chromosome 2q34-q35 in the case of the human type A and B IL-8 receptors (33) and to chromosome 19q13.3 for the formyl peptide and C5a receptors(34) .

The amino-terminal domains represent the areas of greatest sequence divergence between the mJE and mMIP-1alpha receptors. The amino termini of the receptors for thrombin(35) , thyrotropin(36) , C5a(37) , and IL-8 (38) participate in the binding of their respective ligands. Taken together, these observations suggest that divergence of this domain in the mJE and mMIP-1alpha receptors may contribute to their different agonist specificities. To test this hypothesis, we constructed two chimeric receptors in which the amino-terminal domains were exchanged between the mJE receptor and the mMIP-1alpha receptor. Analysis of the signaling properties of these two chimeras in Xenopus oocytes indicated that the amino terminus of the mJE receptor, but not the mMIP-1alpha receptor, was critical for signaling. This result is in agreement with recent results obtained using the human MCP-1 receptor,^2 and suggests that distinct mechanisms of ligand binding have evolved within the C-C chemokine receptor family. Since the first extracellular loop of the mMIP-1alpha receptor and mJE receptor are identical, it is likely that the second and third extracellular loops of the mMIP-1alpha-R will be found to mediate ligand binding and specificity.

In summary, we have cloned two novel murine receptors that appear to define a family of C-C chemokine receptors clustered on chromosome 9. Through the construction of receptor chimeras, we have demonstrated that signaling of the mJE receptor, but not the mMIP-1alpha receptor, is critically dependent upon ligand interaction with the receptor amino terminus. The identification of the murine JE receptor represents an important step in the creation of genetically modified mice to probe the role of JE/MCP-1 in models of human disease.


FOOTNOTES

*
This work was supported in part by National Institutes of Health Grants HL52773 (to I. F. C.), HL30568 (to A. J. L.), and a research fellowship from the California Chapter of the American Heart Association (to F. S. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) U47035 [GenBank](JE-R) and U47036 [GenBank](mMIP1alphaR).

§
To whom correspondence should be addressed: Gladstone Institute of Cardiovascular Disease, P.O. Box 419100, San Francisco, CA 94141-9100. Tel.: 415-826-7500; Fax: 415-285-5632.

(^1)
The abbreviations used are: MCP-1, monocyte chemoattractant protein 1; IL, interleukin; RANTES, regulated on activation, normal T cell-expressed and secreted; MIP, macrophage inflammatory protein; TM, transmembrane; HEK, human embryonic kidney; RFLV, restriction fragment length variant; MIP-1alpha-R, macrophage inflammatory protein 1alpha receptor; kb, kilobase(s); PCR, polymerase chain reaction; PIPES, 1,4-piperazinediethanesulfonic acid.

(^2)
F. S. Monteclaro and I. F. Charo, unpublished observations.

(^3)
I. F. Charo and A. J. Lusis, unpublished observations.


ACKNOWLEDGEMENTS

We thank Yu-Rong Xia for assistance in the chromosomal localization studies, Susannah White for typing the manuscript, Amy Corder and John Carroll for preparation of the figures, and Gary Howard for editorial assistance.


REFERENCES

  1. Oppenheim, J. J., Zachariae, C. O. C., Mukaida, N., and Matsushima, K. (1991) Annu. Rev. Immunol. 9, 617-648 [CrossRef][Medline] [Order article via Infotrieve]
  2. Rollins, B. J. (1991) Cancer Cells 3, 517-524 [Medline] [Order article via Infotrieve]
  3. Schall, T. J. (1994) in The Cytokine Handbook (Thomson, A. W., ed.) 2nd Ed, pp. 419-460, Academic Press, London
  4. Murphy, P. M. (1994) Annu. Rev. Immunol. 12, 593-633 [CrossRef][Medline] [Order article via Infotrieve]
  5. Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., and Williams, T. J. (1994) J. Exp. Med. 179, 881-887 [Abstract]
  6. Kelner, G. S., Kennedy, J., Bacon, K. B., Kleyensteuber, S., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Bazan, J. F., Moore, K. W., Schall, T. J., and Zlotnik, A. (1994) Science 266, 1395-1399 [Medline] [Order article via Infotrieve]
  7. Cochran, B. H., Reffel, A. C., and Stiles, C. D. (1983) Cell 33, 939-947 [Medline] [Order article via Infotrieve]
  8. Rollins, B. J., Morrison, E. D., and Stiles, C. D. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3738-3742 [Abstract]
  9. Ernst, C. A., Zhang, Y. J., Hancock, P. R., Rutledge, B. J., Corless, C. L., and Rollins, B. J. (1994) J. Immunol. 152, 3541-3549 [Abstract/Free Full Text]
  10. Gillitzer, R., Wolff, K., Tong, D., Müller, C., Yoshimura, T., Hartmann, A. A., Stingl, G., and Berger, R. (1993) J. Invest. Dermatol. 101, 127-131 [Abstract]
  11. Antoniades, H. N., Neville-Golden, J., Galanopoulos, T., Kradin, R. L., Valente, A. J., and Graves, D. T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5371-5375 [Abstract]
  12. Koch, A. E., Kunkel, S. L., Harlow, L. A., Johnson, B., Evanoff, H. L., Haines, G. K., Burdick, M. D., Pope, R. M., and Strieter, R. M. (1992) J. Clin. Invest. 90, 772-779 [Medline] [Order article via Infotrieve]
  13. Nelken, N. A., Coughlin, S. R., Gordon, D., and Wilcox, J. N. (1991) J. Clin. Invest. 88, 1121-1127 [Medline] [Order article via Infotrieve]
  14. Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., and Steinberg, D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5252-5256 [Abstract]
  15. Liao, F., Berliner, J. A., Mehrabian, M., Navab, M., Demer, L. L., Lusis, A. J., and Fogelman, A. M. (1991) J. Clin. Invest. 87, 2253-2257 [Medline] [Order article via Infotrieve]
  16. Rollins, B. J., and Sunday, M. E. (1991) Mol. Cell. Biol. 11, 3125-3131 [Medline] [Order article via Infotrieve]
  17. Holmes, W. E., Lee, J., Kuang, W.-J., Rice, G. C., and Wood, W. I. (1991) Science 253, 1278-1280 [Medline] [Order article via Infotrieve]
  18. Murphy, P. M., and Tiffany, H. L. (1991) Science 253, 1280-1283 [Medline] [Order article via Infotrieve]
  19. Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J. (1993) Cell 72, 415-425 [Medline] [Order article via Infotrieve]
  20. Gao, J.-L., Kuhns, D. B., Tiffany, H. L., McDermott, D., Li, X., Francke, U., and Murphy, P. M. (1993) J. Exp. Med. 177, 1421-1427 [Abstract]
  21. Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J., and Coughlin, S. R. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2752-2756 [Abstract]
  22. Myers, S. J., Wong, L. M., and Charo, I. F. (1995) J. Biol. Chem. 270, 5786-5792 [Abstract/Free Full Text]
  23. Cacalano, G., Lee, J., Kikly, K., Ryan, A. M., Pitts-Meek, S., Hultgren, B., Wood, W. I., and Moore, M. W. (1994) Science 265, 682-684 [Medline] [Order article via Infotrieve]
  24. Gao, J.-L., and Murphy, P. M. (1995) J. Biol. Chem. 270, 17494-17501 [Abstract/Free Full Text]
  25. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract]
  26. Ishii, K., Hein, L., Kobilka, B., and Coughlin, S. R. (1993) J. Biol. Chem. 268, 9780-9786 [Abstract/Free Full Text]
  27. Munson, P. J., and Rodbard, D. (1980) Anal. Biochem. 107, 220-239 [Medline] [Order article via Infotrieve]
  28. Warden, C. H., Davis, R. C., Yoon, M.-Y., Hui, D. Y., Svenson, K., Xia, Y.-R., Diep, A., He, K.-Y., and Lusis, A. J. (1993) J. Lipid Res. 34, 1451-1455 [Abstract]
  29. Copeland, N. G., Jenkins, N. A., Gilbert, D. J., Eppig, J. T., Maltais, L. J., Miller, J. C., Dietrich, W. F., Weaver, A., Lincoln, S. E., Steen, R. G., Stein, L. D., Nadeau, J. H., and Lander, E. S. (1993) Science 262, 57-66 [Medline] [Order article via Infotrieve]
  30. Franci, C., Wong, L. M., Van Damme, J., Proost, P., and Charo, I. F. (1995) J. Immunol. 154, 6511-6517 [Abstract/Free Full Text]
  31. Thirion, S., Nys, G., Fiten, P., Masure, S., Van Damme, J., and Opdenakker, G. (1994) Biochem. Biophys. Res. Commun. 201, 493-499 [CrossRef][Medline] [Order article via Infotrieve]
  32. Siciliano, S. J., Rollins, T. E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H., and Springer, M. S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1214-1218 [Abstract]
  33. Ahuja, S. K., Özçelik, T., Milatovitch, A., Francke, U., and Murphy, P. M. (1992) Nat. Genet. 2, 31-36 [Medline] [Order article via Infotrieve]
  34. Gerard, N. P., Bao, L., Xiao-Ping, H., Eddy, R. L., Jr., Shows, T. B., and Gerard, C. (1993) Biochemistry 32, 1243-1250 [Medline] [Order article via Infotrieve]
  35. Vu, T.-K. H., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. (1991) Cell 64, 1057-1068 [Medline] [Order article via Infotrieve]
  36. Wadsworth, H. L., Chazenbalk, G. D., Nagayama, Y., Russo, D., and Rapoport, B. (1990) Science 249, 1423-1425 [Medline] [Order article via Infotrieve]
  37. DeMartino, J. A., Van Riper, G., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., and Springer, M. S. (1994) J. Biol. Chem. 269, 14446-14450 [Abstract/Free Full Text]
  38. Gayle, R. B., III, Sleath, P. R., Srinivason, S., Birks, C. W., Weerawarna, K. S., Cerretti, D. P., Kozlosky, C. J., Nelson, N., Vanden Bos, T., and Beckmann, M. P. (1993) J. Biol. Chem. 268, 7283-7289 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.